Hicks RJ - Search Results

1

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Hertzberg M, Gandhi MK, Trotman J, Butcher B, Taper J, Johnston A, Gill D, Ho SJ, Cull G, Fay K, Chong G, Grigg A, Lewis ID, Milliken S, Renwick W, Hahn U, Filshie R, Kannourakis G, Watson AM, Warburton P, Wirth A, Seymour JF, Hofman MS, Hicks RJ; Australasian Leukaemia Lymphoma Group (ALLG). Hertzberg M, et al. Among authors: hicks rj. Haematologica. 2017 Feb;102(2):356-363. doi: 10.3324/haematol.2016.154039. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28143954 Free PMC article. Clinical Trial.

2

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, Ware RE, Ball DL. MacManus MP, et al. Among authors: hicks rj. Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):287-93. doi: 10.1016/s0360-3016(01)01477-8. Int J Radiat Oncol Biol Phys. 2001. PMID: 11380213 Clinical Trial.

3

F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.

Mac Manus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E, Khaw P, Wirth A, Rischin D, McKenzie A. Mac Manus MP, et al. Among authors: hicks rj. Cancer. 2001 Aug 15;92(4):886-95. doi: 10.1002/1097-0142(20010815)92:4<886::aid-cncr1397>3.0.co;2-v. Cancer. 2001. PMID: 11550162

4

Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center.

Mac Manus MP, Wong K, Hicks RJ, Matthews JP, Wirth A, Ball DL. Mac Manus MP, et al. Among authors: hicks rj. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):351-61. doi: 10.1016/s0360-3016(01)02673-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872280

5

Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.

Wirth A, Seymour JF, Hicks RJ, Ware R, Fisher R, Prince M, MacManus MP, Ryan G, Januszewicz H, Wolf M. Wirth A, et al. Among authors: hicks rj. Am J Med. 2002 Mar;112(4):262-8. doi: 10.1016/s0002-9343(01)01117-2. Am J Med. 2002. PMID: 11893364

6

Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy.

MacManus MP, Hicks RJ, Ball DL, Ciavarella F, Binns D, Hogg A, Kalff V, Ware R, Wirth A, Salminen E, McKenzie A. MacManus MP, et al. Among authors: hicks rj. Australas Radiol. 2001 Nov;45(4):483-90. doi: 10.1046/j.1440-1673.2001.00960.x. Australas Radiol. 2001. PMID: 11903182

7

Discordant response to chemotherapy detected by PET scanning: unveiling of a second primary cancer.

Blum R, Prince HM, Hicks RJ, Patrikeos A, Seymour J. Blum R, et al. Among authors: hicks rj. Am J Clin Oncol. 2002 Aug;25(4):368-70. doi: 10.1097/00000421-200208000-00010. Am J Clin Oncol. 2002. PMID: 12151967

8

Diffuse large B-cell non-Hodgkin's lymphoma presenting as Sister Joseph's nodule.

Tam C, Turner H, Hicks RJ, Seymour JF. Tam C, et al. Among authors: hicks rj. Leuk Lymphoma. 2002 Oct;43(10):2055-7. doi: 10.1080/1042819021000016005. Leuk Lymphoma. 2002. PMID: 12481909 Review.

9

FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy--survival correlates with metastatic disease burden.

MacManus MR, Hicks R, Fisher R, Rischin D, Michael M, Wirth A, Ball DL. MacManus MR, et al. Acta Oncol. 2003;42(1):48-54. doi: 10.1080/0891060310002230. Acta Oncol. 2003. PMID: 12665331

10

Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma.

Blum RH, Seymour JF, Wirth A, MacManus M, Hicks RJ. Blum RH, et al. Among authors: hicks rj. Clin Lymphoma. 2003 Jun;4(1):43-9. doi: 10.3816/clm.2003.n.013. Clin Lymphoma. 2003. PMID: 12837154

11

A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma.

Mileshkin L, Blum R, Seymour JF, Patrikeos A, Hicks RJ, Prince HM. Mileshkin L, et al. Among authors: hicks rj. Eur J Haematol. 2004 Jan;72(1):32-7. doi: 10.1046/j.0902-4441.2004.00177.x. Eur J Haematol. 2004. PMID: 14962260

12

Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience.

Blum R, MacManus MP, Rischin D, Michael M, Ball D, Hicks RJ. Blum R, et al. Among authors: hicks rj. Am J Clin Oncol. 2004 Apr;27(2):164-71. doi: 10.1097/01.coc.0000054889.58718.6f. Am J Clin Oncol. 2004. PMID: 15057156

13

Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management options.

Hönemann D, Prince HM, Hicks RJ, Seymour JF. Hönemann D, et al. Among authors: hicks rj. Ann Hematol. 2005 Feb;84(2):118-21. doi: 10.1007/s00277-004-0953-9. Epub 2004 Sep 25. Ann Hematol. 2005. PMID: 15452669

14

PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy.

Roberts KB, Manus MP, Hicks RJ, Rischin D, Wirth A, Wright GM, Ball DL. Roberts KB, et al. Among authors: hicks rj. Lung Cancer. 2005 Jan;47(1):49-57. doi: 10.1016/j.lungcan.2004.06.014. Lung Cancer. 2005. PMID: 15603854

15

Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.

Mac Manus MP, Hicks RJ, Matthews JP, Wirth A, Rischin D, Ball DL. Mac Manus MP, et al. Among authors: hicks rj. Lung Cancer. 2005 Jul;49(1):95-108. doi: 10.1016/j.lungcan.2004.11.024. Epub 2005 Feb 17. Lung Cancer. 2005. PMID: 15949595 Clinical Trial.

16

Initial staging of lymphoma with positron emission tomography and computed tomography.

Hicks RJ, Mac Manus MP, Seymour JF. Hicks RJ, et al. Semin Nucl Med. 2005 Jul;35(3):165-75. doi: 10.1053/j.semnuclmed.2005.02.003. Semin Nucl Med. 2005. PMID: 16098290 Review.

17

Primary skeletal muscle marginal zone lymphoma with persistent tissue tropism and PET-avidity.

Gill SI, Gibbs SD, Hicks RJ, Seymour JF. Gill SI, et al. Among authors: hicks rj. Leuk Lymphoma. 2006 Jan;47(1):117-20. doi: 10.1080/10428190500174984. Leuk Lymphoma. 2006. PMID: 16321835

18

Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.

Cachin F, Prince HM, Hogg A, Ware RE, Hicks RJ. Cachin F, et al. Among authors: hicks rj. J Clin Oncol. 2006 Jul 1;24(19):3026-31. doi: 10.1200/JCO.2005.04.6326. Epub 2006 May 22. J Clin Oncol. 2006. PMID: 16717291 Clinical Trial.

19

Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma.

Leahy MF, Seymour JF, Hicks RJ, Turner JH. Leahy MF, et al. Among authors: hicks rj. J Clin Oncol. 2006 Sep 20;24(27):4418-25. doi: 10.1200/JCO.2005.05.3470. Epub 2006 Aug 28. J Clin Oncol. 2006. PMID: 16940276 Clinical Trial.

20

Positron emission tomography of stage IV mucosa-associated lymphoid tissue lymphoma confined to the four major salivary glands.

Mac Manus MP, Ryan G, Lau E, Wirth A, Hicks RJ. Mac Manus MP, et al. Among authors: hicks rj. Australas Radiol. 2007 Feb;51(1):68-70. doi: 10.1111/j.1440-1673.2006.01642.x. Australas Radiol. 2007. PMID: 17217492

21

Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.

Ng AP, Wirth A, Seymour JF, Lee M, Hogg A, Januszewicz H, Wolf M, Prince HM, Macmanus M, Hicks RJ. Ng AP, et al. Among authors: hicks rj. Leuk Lymphoma. 2007 Mar;48(3):596-600. doi: 10.1080/10428190601099965. Leuk Lymphoma. 2007. PMID: 17454604

22

Overview of early response assessment in lymphoma with FDG-PET.

MacManus MP, Seymour JF, Hicks RJ. MacManus MP, et al. Among authors: hicks rj. Cancer Imaging. 2007;7(1):10-8. doi: 10.1102/1470-7330.2007.0004. Cancer Imaging. 2007. PMID: 17766210 Free PMC article. Review.

23

Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma.

Wirth A, Foo M, Seymour JF, Macmanus MP, Hicks RJ. Wirth A, et al. Among authors: hicks rj. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):213-9. doi: 10.1016/j.ijrobp.2007.09.051. Epub 2008 Mar 4. Int J Radiat Oncol Biol Phys. 2008. PMID: 18295982

24

A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy.

Bishton MJ, Hicks RJ, Westerman DA, Prince MH, Wolf M, Seymour JF. Bishton MJ, et al. Among authors: hicks rj. Haematologica. 2008 May;93(5):789-90. doi: 10.3324/haematol.12253. Haematologica. 2008. PMID: 18450737 Free article. Clinical Trial. No abstract available.

25

Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set.

Bishton MJ, Hicks RJ, Prince HM, Ritchie DS, Wolf M, Seymour JF. Bishton MJ, et al. Among authors: hicks rj. Leukemia. 2008 Dec;22(12):2259-60; author reply 2260-1. doi: 10.1038/leu.2008.116. Epub 2008 May 15. Leukemia. 2008. PMID: 18480835 No abstract available.

26

Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab.

Bishton MJ, Leahy MF, Hicks RJ, Turner JH, McQuillan AD, Seymour JF. Bishton MJ, et al. Among authors: hicks rj. Ann Oncol. 2008 Sep;19(9):1629-33. doi: 10.1093/annonc/mdn172. Epub 2008 Jun 2. Ann Oncol. 2008. PMID: 18522934 Free article.

27

[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.

Gill S, Wolf M, Prince HM, Januszewicz H, Ritchie D, Hicks RJ, Seymour JF. Gill S, et al. Among authors: hicks rj. Clin Lymphoma Myeloma. 2008 Jun;8(3):159-65. doi: 10.3816/CLM.2008.n.019. Clin Lymphoma Myeloma. 2008. PMID: 18650179

28

What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?

Gill S, Hicks RJ, Seymour JF. Gill S, et al. Among authors: hicks rj. Leuk Lymphoma. 2008 Sep;49(9):1653-6. doi: 10.1080/10428190802311433. Leuk Lymphoma. 2008. PMID: 18798097 Review. No abstract available.

29

Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma.

Kim PJ, Hicks RJ, Wirth A, Ryan G, Seymour JF, Prince HM, Mac Manus MP. Kim PJ, et al. Among authors: hicks rj. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):740-6. doi: 10.1016/j.ijrobp.2008.08.037. Epub 2008 Nov 27. Int J Radiat Oncol Biol Phys. 2009. PMID: 19038505

30

Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.

Lau EW, Drummond KJ, Ware RE, Drummond E, Hogg A, Ryan G, Grigg A, Callahan J, Hicks RJ. Lau EW, et al. Among authors: hicks rj. J Clin Neurosci. 2010 Jan;17(1):43-9. doi: 10.1016/j.jocn.2009.05.009. Epub 2009 Dec 9. J Clin Neurosci. 2010. PMID: 20004582

31

Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma.

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Leuk Lymphoma. 2010 Feb;51(2):183-5. doi: 10.3109/10428190903494331. Leuk Lymphoma. 2010. PMID: 20038239 No abstract available.

32

Breast lymphatic drainage via the pulmonary lymphatic system.

Barber TW, Hofman MS, Hicks RJ. Barber TW, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2203. doi: 10.1007/s00259-010-1593-z. Epub 2010 Sep 7. Eur J Nucl Med Mol Imaging. 2010. PMID: 20821209 No abstract available.

33

Restaging: should we percist without pattern recognition?

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. J Nucl Med. 2010 Dec;51(12):1830-2. doi: 10.2967/jnumed.110.079293. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078792 Free article. No abstract available.

34

Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome.

Yeung JM, Kalff V, Hicks RJ, Drummond E, Link E, Taouk Y, Michael M, Ngan S, Lynch AC, Heriot AG. Yeung JM, et al. Among authors: hicks rj. Dis Colon Rectum. 2011 May;54(5):518-25. doi: 10.1007/DCR.0b013e31820b36f0. Dis Colon Rectum. 2011. PMID: 21471751

35

Imaging in follicular NHL.

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Best Pract Res Clin Haematol. 2011 Jun;24(2):165-77. doi: 10.1016/j.beha.2011.02.005. Epub 2011 May 4. Best Pract Res Clin Haematol. 2011. PMID: 21658616 Review.

36

Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system.

Beauregard JM, Hofman MS, Pereira JM, Eu P, Hicks RJ. Beauregard JM, et al. Among authors: hicks rj. Cancer Imaging. 2011 Jun 15;11(1):56-66. doi: 10.1102/1470-7330.2011.0012. Cancer Imaging. 2011. PMID: 21684829 Free PMC article.

37

The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable.

Barber TW, Hofman MS, Thomson BN, Hicks RJ. Barber TW, et al. Among authors: hicks rj. Eur J Surg Oncol. 2012 Jan;38(1):64-71. doi: 10.1016/j.ejso.2011.08.129. Epub 2011 Sep 8. Eur J Surg Oncol. 2012. PMID: 21906907

38

68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphy.

Hofman MS, Beauregard JM, Barber TW, Neels OC, Eu P, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. J Nucl Med. 2011 Oct;52(10):1513-9. doi: 10.2967/jnumed.111.093344. Epub 2011 Sep 9. J Nucl Med. 2011. PMID: 21908388 Free article.

39

The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy.

Beauregard JM, Hofman MS, Kong G, Hicks RJ. Beauregard JM, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):50-6. doi: 10.1007/s00259-011-1937-3. Epub 2011 Sep 20. Eur J Nucl Med Mol Imaging. 2012. PMID: 21932117

40

White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism.

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. EJNMMI Res. 2011 Jun 7;1(1):2. doi: 10.1186/2191-219X-1-2. EJNMMI Res. 2011. PMID: 22214514 Free PMC article.

41

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours.

Hofman MS, Kong G, Neels OC, Eu P, Hong E, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. J Med Imaging Radiat Oncol. 2012 Feb;56(1):40-7. doi: 10.1111/j.1754-9485.2011.02327.x. J Med Imaging Radiat Oncol. 2012. PMID: 22339744

42

Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients.

Guy SD, Tramontana AR, Worth LJ, Lau E, Hicks RJ, Seymour JF, Thursky KA, Slavin MA. Guy SD, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1348-55. doi: 10.1007/s00259-012-2143-7. Epub 2012 May 15. Eur J Nucl Med Mol Imaging. 2012. PMID: 22584486 Clinical Trial.

43

Changing paradigms with molecular imaging of neuroendocrine tumors.

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Discov Med. 2012 Jul;14(74):71-81. Discov Med. 2012. PMID: 22846204 Free article. Review.

44

Not-so-random errors: randomized controlled trials are not the only evidence of the value of PET.

Hicks RJ, Ware RE, Hofman MS. Hicks RJ, et al. J Nucl Med. 2012 Nov;53(11):1820-2; author reply 1822-1824. doi: 10.2967/jnumed.112.111351. Epub 2012 Oct 3. J Nucl Med. 2012. PMID: 23035129 Free article. No abstract available.

45

Is there still a role for SPECT-CT in oncology in the PET-CT era?

Hicks RJ, Hofman MS. Hicks RJ, et al. Nat Rev Clin Oncol. 2012 Dec;9(12):712-20. doi: 10.1038/nrclinonc.2012.188. Epub 2012 Nov 13. Nat Rev Clin Oncol. 2012. PMID: 23149896 Review.

46

Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.

Clifton-Bligh RJ, Hofman MS, Duncan E, Sim IeW, Darnell D, Clarkson A, Wong T, Walsh JP, Gill AJ, Ebeling PR, Hicks RJ. Clifton-Bligh RJ, et al. Among authors: hicks rj. J Clin Endocrinol Metab. 2013 Feb;98(2):687-94. doi: 10.1210/jc.2012-3642. Epub 2013 Jan 7. J Clin Endocrinol Metab. 2013. PMID: 23295468

47

Not-so-random errors: randomized controlled trials are not the only evidence of the value of PET--rebuttal.

Hicks RJ, Hofman MS, Ware RE. Hicks RJ, et al. J Nucl Med. 2013 Mar;54(3):492. doi: 10.2967/jnumed.112.116020. Epub 2013 Jan 18. J Nucl Med. 2013. PMID: 23334726 Free article. No abstract available.

48

Let's get SEERious: more accurate staging with consequent high management impact is not just stage migration.

Hofman MS, Ball DL, Mac Manus MP, Ware R, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. J Clin Oncol. 2013 Feb 20;31(6):819. doi: 10.1200/JCO.2012.46.5872. Epub 2013 Jan 22. J Clin Oncol. 2013. PMID: 23341532 No abstract available.

49

Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesions.

Beauregard JM, Giraudet AL, Aide N, Hofman MS, Blum R, Drummond E, Roselt P, Hicks RJ. Beauregard JM, et al. Among authors: hicks rj. Nucl Med Commun. 2013 Jun;34(6):521-6. doi: 10.1097/MNM.0b013e3283606669. Nucl Med Commun. 2013. PMID: 23542911 Clinical Trial.

50

High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma.

Kashyap R, Lau E, George A, Seymour JF, Lade S, Hicks RJ, Hofman MS. Kashyap R, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1330-6. doi: 10.1007/s00259-013-2429-4. Epub 2013 May 8. Eur J Nucl Med Mol Imaging. 2013. PMID: 23653244

51

Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.

Cheah CY, Hofman MS, Dickinson M, Wirth A, Westerman D, Harrison SJ, Burbury K, Wolf M, Januszewicz H, Herbert K, Prince HM, Carney DA, Ritchie DS, Hicks RJ, Seymour JF. Cheah CY, et al. Among authors: hicks rj. Br J Cancer. 2013 Jul 23;109(2):312-7. doi: 10.1038/bjc.2013.338. Epub 2013 Jun 27. Br J Cancer. 2013. PMID: 23807169 Free PMC article.

52

Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion.

Kashyap R, Jackson P, Hofman MS, Eu P, Beauregard JM, Zannino D, Hicks RJ. Kashyap R, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1853-60. doi: 10.1007/s00259-013-2504-x. Epub 2013 Jul 18. Eur J Nucl Med Mol Imaging. 2013. PMID: 23864305

53

High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT.

Callahan J, Hofman MS, Siva S, Kron T, Schneider ME, Binns D, Eu P, Hicks RJ. Callahan J, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):343-9. doi: 10.1007/s00259-013-2607-4. Epub 2013 Nov 6. Eur J Nucl Med Mol Imaging. 2014. PMID: 24196920

54

Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):211-3. doi: 10.1007/s00259-013-2621-6. Epub 2013 Nov 13. Eur J Nucl Med Mol Imaging. 2014. PMID: 24221244 No abstract available.

55

An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging.

Jackson PA, Beauregard JM, Hofman MS, Kron T, Hogg A, Hicks RJ. Jackson PA, et al. Among authors: hicks rj. Med Phys. 2013 Nov;40(11):112503. doi: 10.1118/1.4824318. Med Phys. 2013. PMID: 24320462

56

Segmental hyperperfusion in lobar pneumonia visualized with respiratory-gated four-dimensional pulmonary perfusion positron emission tomography-computed tomography.

Hofman MS, Callahan J, Eu P, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Am J Respir Crit Care Med. 2014 Jan 1;189(1):104-5. doi: 10.1164/rccm.201307-1196IM. Am J Respir Crit Care Med. 2014. PMID: 24381992 No abstract available.

57

Validating and improving CT ventilation imaging by correlating with ventilation 4D-PET/CT using 68Ga-labeled nanoparticles.

Kipritidis J, Siva S, Hofman MS, Callahan J, Hicks RJ, Keall PJ. Kipritidis J, et al. Among authors: hicks rj. Med Phys. 2014 Jan;41(1):011910. doi: 10.1118/1.4856055. Med Phys. 2014. PMID: 24387518

58

Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.

Hughes B, Mileshkin L, Townley P, Gitlitz B, Eaton K, Mitchell P, Hicks R, Wood K, Amler L, Fine BM, Loecke D, Pirzkall A. Hughes B, et al. Oncologist. 2014 Feb;19(2):175-6. doi: 10.1634/theoncologist.2013-0026. Epub 2014 Jan 23. Oncologist. 2014. PMID: 24457379 Free PMC article. Clinical Trial.

59

Enhanced white adipose tissue metabolism in iatrogenic Cushing's syndrome with FDG PET/CT.

Pattison DA, Hofman MS, Lau E, Ware R, Hicks RJ. Pattison DA, et al. Among authors: hicks rj. J Clin Endocrinol Metab. 2014 Sep;99(9):3041-2. doi: 10.1210/jc.2013-4090. Epub 2014 Feb 14. J Clin Endocrinol Metab. 2014. PMID: 24527716 No abstract available.

60

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT).

Kong G, Thompson M, Collins M, Herschtal A, Hofman MS, Johnston V, Eu P, Michael M, Hicks RJ. Kong G, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1831-44. doi: 10.1007/s00259-014-2788-5. Epub 2014 May 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24844348 Free PMC article.

61

Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.

Teng J, Abell S, Hicks RJ, Hofman MS, Sachithanandan N, McKelvie P, MacIsaac RJ. Teng J, et al. Among authors: hicks rj. Clin Endocrinol (Oxf). 2014 Dec;81(6):940-2. doi: 10.1111/cen.12519. Epub 2014 Jul 2. Clin Endocrinol (Oxf). 2014. PMID: 24890549 No abstract available.

62

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cheson BD. Barrington SF, et al. Among authors: hicks rj. J Clin Oncol. 2014 Sep 20;32(27):3048-58. doi: 10.1200/JCO.2013.53.5229. J Clin Oncol. 2014. PMID: 25113771 Free PMC article.

63

Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours.

Kashyap R, Hofman MS, Michael M, Kong G, Akhurst T, Eu P, Zannino D, Hicks RJ. Kashyap R, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):176-85. doi: 10.1007/s00259-014-2906-4. Epub 2014 Sep 11. Eur J Nucl Med Mol Imaging. 2015. PMID: 25209134 Clinical Trial.

64

A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer.

Siva S, Callahan J, Kron T, Martin OA, MacManus MP, Ball DL, Hicks RJ, Hofman MS. Siva S, et al. Among authors: hicks rj. BMC Cancer. 2014 Oct 2;14:740. doi: 10.1186/1471-2407-14-740. BMC Cancer. 2014. PMID: 25277150 Free PMC article. Clinical Trial.

65

Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning.

Siva S, Devereux T, Ball DL, MacManus MP, Hardcastle N, Kron T, Bressel M, Foroudi F, Plumridge N, Steinfort D, Shaw M, Callahan J, Hicks RJ, Hofman MS. Siva S, et al. Among authors: hicks rj. Technol Cancer Res Treat. 2016 Feb;15(1):114-21. doi: 10.1177/1533034614565534. Epub 2015 Jan 9. Technol Cancer Res Treat. 2016. PMID: 25575575 Free article.

66

68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTA.

Hofman M, Binns D, Johnston V, Siva S, Thompson M, Eu P, Collins M, Hicks RJ. Hofman M, et al. Among authors: hicks rj. J Nucl Med. 2015 Mar;56(3):405-9. doi: 10.2967/jnumed.114.147843. Epub 2015 Feb 12. J Nucl Med. 2015. PMID: 25678493 Free article. Clinical Trial.

67

Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al.

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller S, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cavalli F, Lister TA, Cheson BD. Barrington SF, et al. Among authors: hicks rj. J Clin Oncol. 2015 Apr 1;33(10):1221-3. doi: 10.1200/JCO.2014.59.9373. Epub 2015 Feb 17. J Clin Oncol. 2015. PMID: 25691678 No abstract available.

68

Re: palliative bypass for small bowel carcinoid with mesenteric mass and vascular encasement.

Thomson BN, Hofman MS, Hicks RJ. Thomson BN, et al. Among authors: hicks rj. ANZ J Surg. 2015 Mar;85(3):197. doi: 10.1111/ans.12935. ANZ J Surg. 2015. PMID: 25732391 No abstract available.

69

Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.

Hofman MS, Lau WF, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Radiographics. 2015 Mar-Apr;35(2):500-16. doi: 10.1148/rg.352140164. Radiographics. 2015. PMID: 25763733

70

Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).

Hofman MS, Michael M, Kashyap R, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. J Nucl Med. 2015 Jun;56(6):968-9. doi: 10.2967/jnumed.115.154500. Epub 2015 Mar 26. J Nucl Med. 2015. PMID: 25814516 Free article. No abstract available.

71

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.

Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, Miklos D, Advani RH, Levy R, Hicks RJ, Hertzberg M, Ohgami RS, Gandhi MK, Diehn M, Alizadeh AA. Kurtz DM, et al. Among authors: hicks rj. Blood. 2015 Jun 11;125(24):3679-87. doi: 10.1182/blood-2015-03-635169. Epub 2015 Apr 17. Blood. 2015. PMID: 25887775 Free PMC article.

72

High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer.

Siva S, Thomas R, Callahan J, Hardcastle N, Pham D, Kron T, Hicks RJ, MacManus MP, Ball DL, Hofman MS. Siva S, et al. Among authors: hicks rj. Radiother Oncol. 2015 May;115(2):157-62. doi: 10.1016/j.radonc.2015.04.013. Epub 2015 Apr 29. Radiother Oncol. 2015. PMID: 25935743 Clinical Trial.

73

Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France.

Le Roux PY, Pelletier-Galarneau M, De Laroche R, Hofman MS, Zuckier LS, Roach P, Vuillez JP, Hicks RJ, Le Gal G, Salaun PY. Le Roux PY, et al. Among authors: hicks rj. J Nucl Med. 2015 Aug;56(8):1212-7. doi: 10.2967/jnumed.115.157743. Epub 2015 Jul 1. J Nucl Med. 2015. PMID: 26135110 Free article.

74

Moving Beyond "Lumpology": PET/CT Imaging of Pheochromocytoma and Paraganglioma.

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Clin Cancer Res. 2015 Sep 1;21(17):3815-7. doi: 10.1158/1078-0432.CCR-15-1073. Epub 2015 Jul 7. Clin Cancer Res. 2015. PMID: 26152741

75

Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.

Campbell BA, Callahan J, Bressel M, Simoens N, Everitt S, Hofman MS, Hicks RJ, Burbury K, MacManus M. Campbell BA, et al. Among authors: hicks rj. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1035-1043. doi: 10.1016/j.ijrobp.2015.04.027. Epub 2015 Apr 22. Int J Radiat Oncol Biol Phys. 2015. PMID: 26194679

76

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.

Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, Binns D, Desmonts C, Salaun PY, Hicks RJ, Aide N. Quak E, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2072-82. doi: 10.1007/s00259-015-3128-0. Epub 2015 Jul 30. Eur J Nucl Med Mol Imaging. 2015. PMID: 26219870 Free PMC article.

77

Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung.

Siva S, Hardcastle N, Kron T, Bressel M, Callahan J, MacManus MP, Shaw M, Plumridge N, Hicks RJ, Steinfort D, Ball DL, Hofman MS. Siva S, et al. Among authors: hicks rj. Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):408-17. doi: 10.1016/j.ijrobp.2015.06.005. Epub 2015 Jun 9. Int J Radiat Oncol Biol Phys. 2015. PMID: 26275510

78

Accuracy and Utility of Deformable Image Registration in (68)Ga 4D PET/CT Assessment of Pulmonary Perfusion Changes During and After Lung Radiation Therapy.

Hardcastle N, Hofman MS, Hicks RJ, Callahan J, Kron T, MacManus MP, Ball DL, Jackson P, Siva S. Hardcastle N, et al. Among authors: hicks rj. Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):196-204. doi: 10.1016/j.ijrobp.2015.05.011. Epub 2015 May 14. Int J Radiat Oncol Biol Phys. 2015. PMID: 26279034

79

Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma.

Kong G, Hofman MS, Murray WK, Wilson S, Wood P, Downie P, Super L, Hogg A, Eu P, Hicks RJ. Kong G, et al. Among authors: hicks rj. J Pediatr Hematol Oncol. 2016 Mar;38(2):87-96. doi: 10.1097/MPH.0000000000000411. J Pediatr Hematol Oncol. 2016. PMID: 26296147

80

Reply to G. Keramida et al.

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller S, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cheson BD. Barrington SF, et al. Among authors: hicks rj. J Clin Oncol. 2015 Dec 1;33(34):4121-2. doi: 10.1200/JCO.2015.63.2125. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304890 No abstract available.

81

Correlation of 68Ga Ventilation-Perfusion PET/CT with Pulmonary Function Test Indices for Assessing Lung Function.

Le Roux PY, Siva S, Steinfort DP, Callahan J, Eu P, Irving LB, Hicks RJ, Hofman MS. Le Roux PY, et al. Among authors: hicks rj. J Nucl Med. 2015 Nov;56(11):1718-23. doi: 10.2967/jnumed.115.162586. Epub 2015 Sep 3. J Nucl Med. 2015. PMID: 26338892 Free article.

82

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.

Keane C, Vari F, Hertzberg M, Cao KA, Green MR, Han E, Seymour JF, Hicks RJ, Gill D, Crooks P, Gould C, Jones K, Griffiths LR, Talaulikar D, Jain S, Tobin J, Gandhi MK. Keane C, et al. Among authors: hicks rj. Lancet Haematol. 2015 Oct;2(10):e445-55. doi: 10.1016/S2352-3026(15)00150-7. Epub 2015 Oct 1. Lancet Haematol. 2015. PMID: 26686046 Clinical Trial.

83

'Hot spot' cardiac ischemia imaging with fluorodeoxyglucose positron emission tomography.

Ferguson MT, Mallia A, Yap K, Wright S, Hicks RJ, Hofman MS. Ferguson MT, et al. Among authors: hicks rj. J Nucl Cardiol. 2016 Dec;23(6):1514-1517. doi: 10.1007/s12350-015-0390-2. Epub 2016 Jan 11. J Nucl Cardiol. 2016. PMID: 26754464 No abstract available.

84

Short and long-term prognostic implications of a low embolic burden in oncology patients diagnosed with symptomatic pulmonary embolism.

Le Roux PY, Burbury K, Hofman MS, Hicks RJ. Le Roux PY, et al. Among authors: hicks rj. Ann Hematol. 2016 Mar;95(4):651-2. doi: 10.1007/s00277-016-2593-2. Epub 2016 Jan 12. Ann Hematol. 2016. PMID: 26754636 No abstract available.

85

Does PET SUV Harmonization Affect PERCIST Response Classification?

Quak E, Le Roux PY, Lasnon C, Robin P, Hofman MS, Bourhis D, Callahan J, Binns DS, Desmonts C, Salaun PY, Hicks RJ, Aide N. Quak E, et al. Among authors: hicks rj. J Nucl Med. 2016 Nov;57(11):1699-1706. doi: 10.2967/jnumed.115.171983. Epub 2016 Jun 9. J Nucl Med. 2016. PMID: 27283930 Free article. Clinical Trial.

86

Intense focal pituitary FDG uptake due to intravascular large B-cell lymphoma in pyrexia of unknown origin.

Pattison DA, Hofman MS, Bazargan A, Colman P, Hicks RJ. Pattison DA, et al. Among authors: hicks rj. Am J Hematol. 2016 Nov;91(11):1167-1168. doi: 10.1002/ajh.24469. Epub 2016 Jul 20. Am J Hematol. 2016. PMID: 27387341 Free article. No abstract available.

87

(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.

Chang CA, Pattison DA, Tothill RW, Kong G, Akhurst TJ, Hicks RJ, Hofman MS. Chang CA, et al. Among authors: hicks rj. Cancer Imaging. 2016 Aug 17;16(1):22. doi: 10.1186/s40644-016-0084-2. Cancer Imaging. 2016. PMID: 27535829 Free PMC article.

88

Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery.

Le Roux PY, Leong TL, Barnett SA, Hicks RJ, Callahan J, Eu P, Manser R, Hofman MS. Le Roux PY, et al. Among authors: hicks rj. Cancer Imaging. 2016 Aug 20;16(1):24. doi: 10.1186/s40644-016-0081-5. Cancer Imaging. 2016. PMID: 27544383 Free PMC article.

89

Gallium-68 EDTA PET/CT for Renal Imaging.

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Semin Nucl Med. 2016 Sep;46(5):448-61. doi: 10.1053/j.semnuclmed.2016.04.002. Semin Nucl Med. 2016. PMID: 27553470 Review.

90

High clinical and morphologic response using ⁹⁰Y-DOTA-octreotate sequenced with ¹⁷⁷Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.

Kong G, Callahan J, Hofman MS, Pattison DA, Akhurst T, Michael M, Eu P, Hicks RJ. Kong G, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):476-489. doi: 10.1007/s00259-016-3527-x. Epub 2016 Sep 27. Eur J Nucl Med Mol Imaging. 2017. PMID: 27678267 Clinical Trial.

91

How We Read Oncologic FDG PET/CT.

Hofman MS, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. Cancer Imaging. 2016 Oct 18;16(1):35. doi: 10.1186/s40644-016-0091-3. Cancer Imaging. 2016. PMID: 27756360 Free PMC article. Review.

92

177Lu-Dotatate for Midgut Neuroendocrine Tumors.

Hofman MS, Michael M, Hicks RJ. Hofman MS, et al. Among authors: hicks rj. N Engl J Med. 2017 Apr 6;376(14):1390-1. doi: 10.1056/NEJMc1701616. N Engl J Med. 2017. PMID: 28382815 No abstract available.

93

The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.

Wong ANM, McArthur GA, Hofman MS, Hicks RJ. Wong ANM, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):67-77. doi: 10.1007/s00259-017-3691-7. Epub 2017 Apr 7. Eur J Nucl Med Mol Imaging. 2017. PMID: 28389693 Review.

94

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions.

Fanti S, Minozzi S, Morigi JJ, Giesel F, Ceci F, Uprimny C, Hofman MS, Eiber M, Schwarzenbock S, Castellucci P, Bellisario C, Chauvie S, Bergesio F, Emmett L, Haberkorn U, Virgolini I, Schwaiger M, Hicks RJ, Krause BJ, Chiti A. Fanti S, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1622-1635. doi: 10.1007/s00259-017-3725-1. Epub 2017 May 23. Eur J Nucl Med Mol Imaging. 2017. PMID: 28536833

95

EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.

Lasnon C, Quak E, Le Roux PY, Robin P, Hofman MS, Bourhis D, Callahan J, Binns DS, Desmonts C, Salaun PY, Hicks RJ, Aide N. Lasnon C, et al. Among authors: hicks rj. EJNMMI Phys. 2017 Dec;4(1):17. doi: 10.1186/s40658-017-0185-4. Epub 2017 May 30. EJNMMI Phys. 2017. PMID: 28560574 Free PMC article.

96

Detection of Synchronous Primary Malignancies with ⁶⁸Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients.

Osman MM, Iravani A, Hicks RJ, Hofman MS. Osman MM, et al. Among authors: hicks rj. J Nucl Med. 2017 Dec;58(12):1938-1942. doi: 10.2967/jnumed.117.190215. Epub 2017 Jun 1. J Nucl Med. 2017. PMID: 28572488 Free article.

97

Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma.

Kong G, Grozinsky-Glasberg S, Hofman MS, Callahan J, Meirovitz A, Maimon O, Pattison DA, Gross DJ, Hicks RJ. Kong G, et al. Among authors: hicks rj. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3278-3287. doi: 10.1210/jc.2017-00816. J Clin Endocrinol Metab. 2017. PMID: 28605448

98

Oligometastatic Renal Cell Carcinoma With Sarcomatoid Differentiation Demonstrating Variable Imaging Phenotypes on ⁶⁸Ga-PSMA and ¹⁸F-FDG PET/CT: A Case Report and Review of the Literature.

Nadebaum DP, Hofman MS, Mitchell CA, Siva S, Hicks RJ. Nadebaum DP, et al. Among authors: hicks rj. Clin Genitourin Cancer. 2017 Aug 23:S1558-7673(17)30250-1. doi: 10.1016/j.clgc.2017.08.009. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28890070 No abstract available.

99

Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.

Thang SP, Lung MS, Kong G, Hofman MS, Callahan J, Michael M, Hicks RJ. Thang SP, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):262-277. doi: 10.1007/s00259-017-3821-2. Epub 2017 Sep 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 28894897

100

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of ⁶⁸Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer.

Hofman MS, Eu P, Jackson P, Hong E, Binns D, Iravani A, Murphy D, Mitchell C, Siva S, Hicks RJ, Young JD, Blower PJ, Mullen GE. Hofman MS, et al. Among authors: hicks rj. J Nucl Med. 2018 Apr;59(4):625-631. doi: 10.2967/jnumed.117.199554. Epub 2017 Oct 6. J Nucl Med. 2018. PMID: 28986512 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters